GlassScriptPhysician profile
William R Silliman
NPI 1174552954
$5,433.98
in general payments reported to CMS, 2019-2025
41 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $218 · 2021: $726 · 2022: $2,409 · 2023: $411 · 2024: $680 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,023.62 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $459.00 | 2019-2024 | Echelon Flex |
| Elucent Medical | $247.20 | 2022-2025 | |
| Allergan, INC. | $232.61 | 2019-2022 | |
| Davol INC. | $210.36 | 2019-2023 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $183.80 | 2019-2022 | |
| Boston Scientific Corporation | $155.33 | 2022-2024 | Spyglass Discover |
| Baudax Bio INC. | $142.00 | 2021 | |
| Hologic Sales and Service, LLC | $140.94 | 2025 | Magtrace |
| Sanara Medtech INC. | $132.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $132.59 | 2023 | Andexxa |
| W. L. Gore & Associates, INC. | $114.11 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Reprise Biomedical, INC. | $94.05 | 2023 | Mirotract, Miro3d, Miro3d Fibers |
| Innovation Technologies INC | $87.71 | 2022 | |
| Innocoll Pharmaceuticals Limited | $80.10 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $77.20 | 2024 | Novosorb Btm |
| Kerecis Limited | $70.31 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $70.31 | 2020-2023 | Gattex |
| Organogenesis INC. | $60.36 | 2024 | |
| Z-Medica, LLC | $57.37 | 2019 | |
| Acera Surgical, INC. | $55.22 | 2024 | Restrata Wound Matrix |
| Fujifilm Healthcare Americas Corporation | $54.77 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $48.50 | 2024 | Exparel |
| Kub Technologies INC. | $48.37 | 2022 | |
| Covidien LP | $42.71 | 2019 | |
| Molli Surgical (US) INC | $42.33 | 2022 | |
| Abbvie INC. | $42.00 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Kci USA, INC. | $37.76 | 2022-2023 | V.A.C. Veraflo |
| Convatec INC. | $35.26 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $33.62 | 2019-2022 | |
| Smith+Nephew, INC. | $30.10 | 2019-2022 | |
| Shire North American Group INC | $29.03 | 2019 | |
| Cook Medical LLC | $27.37 | 2019 | |
| Heron Therapeutics, INC. | $22.63 | 2022 | |
| Baxter Healthcare | $19.16 | 2022 | |
| Dilon Technologies, INC. | $18.52 | 2021 | |
| Myriad Genetic Laboratories, INC. | $17.97 | 2022 | |
| Tela Bio, INC. | $16.36 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kowa Pharmaceuticals America, INC. | $14.36 | 2022 | |
| Celgene Corporation | $14.35 | 2019 | |
| Medela LLC | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Silliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.